Implications of CD36 Gene Variants in Oxidative Stress Markers Between Mexican Patients with Type 2 Diabetes and ST-Segment Elevation Myocardial Infarction
Authors:
- Brenda Parra-ReynaBPBrenda Parra-Reyna
- Iliannis Yisel Roa-BruzónIliannis Yisel Roa-Bruzón
- Texali Candelaria García-GarduñoTGTexali Candelaria García-Garduño
- Luis Felix Duany-AlmiraLDLuis Felix Duany-Almira
- Antonio Quintero-RamosAntonio Quintero-Ramos
- Jorge Ramón Padilla-GutiérrezJPJorge Ramón Padilla-Gutiérrez
- Héctor Enrique Flores-SalinasHFHéctor Enrique Flores-Salinas
- Emmanuel Valdes-AlvaradoEmmanuel Valdes-Alvarado
- José Francisco Muñoz-ValleJMJosé Francisco Muñoz-Valle
- Yeminia ValleYVYeminia Valle
Open Access
- 15 August 2025
- journal article
- research article
- Published by MDPI AG in Antioxidants
- Vol. 14 (8) , 999
Abstract
Type 2 diabetes mellitus (T2DM) affects 90% of diabetes cases and worsens cardiovascular health by causing oxidative stress, which leads to oxidized LDL (oxLDL) and foam cell formation, contributing to atherosclerosis. This study examined the relationship between CD36 gene variants, soluble CD36 (sCD36), oxLDL, and MDA-LDL in T2DM and ST-segment elevation myocardial infarction (STE-T2DM) patients in western Mexico. The analysis included 400 T2DM patients, 400 STE-T2DM patients, and 400 healthy controls. Results showed that STE-T2DM patients were older, mainly male, and had higher rates of smoking, sedentarism, and hypertension. Both diabetic groups exhibited elevated triacylglycerols and low HDL, with significantly higher C-reactive protein in STE-T2DM (p < 0.0001). No significant differences in CD36 gene variant frequencies were found, but sCD36 levels were elevated in STE-T2DM, with associations to specific genotypes. oxLDL was higher in STE-T2DM compared to controls (p = 0.0268). Binary logistic regression analysis identified male sex, younger age, sedentarism, and rs3173798 T/T genotype as independent risk factors for myocardial infarction (AUC: 0.9267, p < 0.0001). Elevated sCD36 levels may reflect atherosclerosis progression in diabetes, indicating the need for further studies to clarify CD36’s role in cardiometabolic dysfunction. These findings highlight CD36’s involvement in oxidative stress responses through its interaction with oxLDL and MDA-LDL, suggesting its potential role as a molecular target in antioxidant defense mechanisms.Keywords
Funding Information
- PROSNI 2023 and 2024, CUCS, University of Guadalajara (UDG)
- APPAC VII 2025, CUCS, UDG
This publication has 39 references indexed in Scilit:
- Investigation of MDA-LDL (malondialdehyde-modified low-density lipoprotein) as a prognostic marker for coronary artery disease in patients with type 2 diabetes mellitusClinica Chimica Acta, 2015
- Modified Low Density Lipoprotein and Lipoprotein-Containing Circulating Immune Complexes as Diagnostic and Prognostic Biomarkers of Atherosclerosis and Type 1 Diabetes Macrovascular DiseaseInternational Journal of Molecular Sciences, 2014
- Admixture and population structure in Mexican-Mestizos based on paternal lineagesJournal of Human Genetics, 2012
- Plasma sCD36 is associated with markers of atherosclerosis, insulin resistance and fatty liver in a nondiabetic healthy populationJournal of Internal Medicine, 2011
- F2-isoprostanes as an indicator and risk factor for coronary heart diseaseFree Radical Biology and Medicine, 2011
- Common CD36 SNPs reduce protein expression and may contribute to a protective atherogenic profileHuman Molecular Genetics, 2010
- Oxidized LDL: Diversity, Patterns of Recognition, and PathophysiologyAntioxidants & Redox Signaling, 2010
- Lipid‐induced Insulin Resistance Is Associated With Increased Monocyte Expression of Scavenger Receptor CD36 and Internalization of Oxidized LDLObesity, 2009
- Effects of amlodipine and candesartan on oxidized LDL level in patients with mild to moderate essential hypertensionBlood Pressure, 2006
- A link between diabetes and atherosclerosis: Glucose regulates expression of CD36 at the level of translationNature Medicine, 2001